Moreover, as mentioned earlier, fucosterol showed the highest binding affinity to LXR-β, indicating that it could be a potential LXR-β agonist, which might play a significant role against AD pathology through maintaining cholesterol homeostasis and Aβ clearance involving ABC/SHREBF1/ApoE-dependent pathways. The gene discussed is APOE; the disease is Alzheimer disease.